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Zoonotic intestinal helminths 
interact with the canine immune 
system by modulating T cell 
responses and preventing dendritic 
cell maturation
Johannes Junginger1, Katharina Raue2, Karola Wolf3,4, Elisabeth Janecek2,  
Veronika M. Stein4,5, Andrea Tipold4, Anne-Rose Günzel-Apel3,4, Christina Strube2 &  
Marion Hewicker-Trautwein1
Parasite co-evolution alongside the mammalian immune system gave rise to several modulatory 
strategies by which they prevent exaggerated pathology and facilitate a longer worm survival. As 
little is known about the immunoregulatory potential of the zoonotic canine parasites Ancylostoma 
caninum and Toxocara canis in the natural host, the present study aimed to investigate whether their 
larval excretory-secretory (ES) products can modulate the canine immune system. We demonstrated 
TcES to increase the frequency of CD4+ Foxp3high T cells, while both AcES and TcES were associated 
with elevated Helios expression in Foxp3high lymphocytes. ES products were further capable of inducing 
IL-10 production by lymphocytes, which was mainly attributed to CD8+ T cells. ES treatment of PBMCs 
prior to mitogen stimulation inhibited polyclonal proliferation of CD4+ and CD8+ T cells. Moreover, 
monocyte-derived ES-pulsed dendritic cells reduced upregulation of MHC-II and CD80 in response to 
lipopolysaccharide. The data showed that regulation of the canine immune system by A. caninum and T. 
canis larvae comprises the modification of antigen-specific and polyclonal T cell responses and dendritic 
cell maturation.
Parasites are responsible for public health problems worldwide with the highest prevalence being attributed to 
intestinal helminths1–3. Helminth infections occur in animals as well as humans3, 4, with Ancylostoma caninum 
and Toxocara canis being two of the most important intestinal nematodes in dogs. For instance, the prevalence 
of T. canis in the definitive host has been reported to range between 1.4 and 30.5% in Europe with the highest 
prevalence usually found in puppies5, 6. Although dogs are required for completion of the life-cycle, parasite larval 
stages are further capable of inducing diseases in paratenic hosts including humans. For example, A. caninum, 
which is closely related to the main human hookworms A. duodenale and Necator americanus, is responsible for 
cutaneous larva migrans and eosinophilic enteritis associated with abdominal pain7, 8. In contrast, T. canis larvae, 
the cause of human toxocariasis along with T. cati, migrate to various organs and thereby cause neurological, 
ocular or other systemic diseases in human patients9, 10.
Remarkably, during their co-evolution alongside the mammalian immune system, parasites have adopted 
several immunomodulatory mechanisms allowing them to prevent exaggerated pathology and thereby to facili-
tate a chronic, long-lasting course of infection enabling completion of their life-cycle11–13. The wide spectrum of 
immune modulation includes interaction with antigen-presenting cells, suppression of pro-inflammatory and 
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induction of anti-inflammatory cytokines, as well as generation of regulatory T cells (Tregs)14–17. Related down-
stream effects are not only beneficial for the worm itself, but being in a parasite-induced pro-regulatory condi-
tion can have further bystander consequences for the host18. For instance, parasitic infections have been shown 
to suppress chronic inflammatory disorders such as inflammatory bowel disease19. Interestingly, this raises the 
question as to whether parasite-related mechanisms represent suitable targets for novel therapeutic strategies20–22. 
Remarkably, it has also been demonstrated that parasite-related immune modulation can have further effects 
including a reduced response to other pathogens or vaccines23–25.
Several studies have shown larval and adult parasitic secretions to play a central role in the parasite-host 
interaction26–28. These so-called ‘excretory-secretory’ (ES) products are mainly released from the parasite’s cuticle, 
oral cavity and secretory glands, and therefore represent the direct interface between the parasite and the host29. 
As revealed by proteomic studies, they comprise a complex mixture of enzymes, mucins, lectins, proteoglycans, 
other proteins, carbohydrates and lipids29–31. ES products have also been shown to directly interact with the host’s 
immune system32. For example, this can include the induction of the Treg-specific transcription factor Foxp3 as 
known for Heligmosomoides polygyrus infection in mice16, or binding the CD11b/CD18 integrin on neutrophils 
by glycoproteins leading to reduced hydrogen peroxide production as demonstrated for Haemonchus contortus33.
Most of the evidence concerning how A. caninum and T. canis interact with the immune system is based on 
murine and human studies. For instance, infection with adult A. caninum is capable of suppressing intestinal 
pathology in dextran sodium sulphate-induced murine colitis, which is associated with dominance of Th2-related 
but suppression of pro-inflammatory cytokines, and recruitment of alternatively activated macrophages and eosin-
ophils34. Similar effects were observed when human peripheral blood mononuclear cells (PBMCs) were stimulated 
with larval/adult ES antigens (AcES) or co-cultivated with living third stage (L3) larvae17. Interestingly, the sup-
pression of pro-inflammatory cytokines and the anti-proliferating effects of AcES are significantly increased in 
patients infected with A. caninum compared to uninfected controls17. Enhancing immunosuppression by inducing 
anti-inflammatory cytokines, such as TGF-β and/or IL-10, has also been shown for T. canis in humans and mice14, 35, 36. 
Its anti-inflammatory potential is further evidenced by in vivo data demonstrating Foxp3 mRNA and protein levels 
to be increased in T. canis-infected mice37. In addition, murine cytokine responses in the context of T. canis infec-
tion are further predominated by high levels of Th2-related cytokines such as IL-4 and IL-535, 38.
In contrast to studies investigating the immune response in humans and mice, little is known about the inter-
action of A. caninum and T. canis with the canine immune system. While investigations into the immunomod-
ulatory effects of A. caninum in the natural host are lacking so far, a few studies suggest an anti-inflammatory 
potential of T. canis in dogs. For instance, increased IL-10 production was demonstrated for PBMCs of pregnant 
dogs when re-exposed to larval T. canis ES (TcES) in vitro, this being associated with lower production of IFN-γ39. 
More recently, a low IFN-γ/IL-10 ratio and dominance of IL-5 was found when canine PBMCs were stimulated 
with extracts of adult T. canis40. Besides investigations focussing on cytokine responses, we recently demon-
strated that Foxp3+ Tregs are elevated in the intestinal mucosa of nematode-infected animals, suggesting that 
parasite-related immune modulation in dogs may also occur on a cellular level41. As responsible mechanisms are 
still unknown, the aim of the present study was to further elucidate the anti-inflammatory effects of A. caninum 
and T. canis larval ES products on canine T cells and dendritic cells (DCs) in vitro.
Results
TcES increases Foxp3high expression in canine CD4+, CD4+ CD8+ and CD4− CD8− T cells. For 
estimating the immunoregulatory capacities of A. caninum and T. canis in the definitive host, larval ES products 
were used to stimulate canine immune cells in vitro. To evaluate whether A. caninum and T. canis larvae share a 
Treg inducing ability, canine PBMCs were cultured in the presence of AcES and TcES for 72 hours and then ana-
lysed with respect to their Foxp3 expression by flow cytometry. This approach demonstrated TcES to be capable of 
increasing the frequency of Foxp3high and Foxp3+ lymphocytes at 150 µg/mL (means of Foxp3high cells: medium 
15.8%, 150 µg/mL TcES 32.9% with p = 0.02; means of Foxp3+ lymphocytes: medium 32.1%, 150 µg/mL TcES 
50.8% with p = 0.04; Fig. 1A). Co-staining for CD4 and CD8 revealed the TcES-associated increase in Foxp3high 
expression to be associated with CD4+, CD4 + CD8+ and CD4- CD8- double-negative T cells (means of Foxp3high 
in CD4+ T cells: medium 18.5%, 150 µg/mL TcES 30.5% with p = 0.006; means of Foxp3high in CD4+ CD8+ 
cells: medium 34.9%, 150 µg/mL TcES 59.5% with p = 0.002; means of Foxp3high in CD4- CD8- cells: medium 
15.6%, 150 µg/mL TcES 29.0% with p = 0.04; Fig. 1B). Treatment with AcES at 150 µg/mL was associated with a 
much lower increase in frequencies of Foxp3high cells within lymphocytes as well as CD4 + CD8+ T cells com-
pared to TcES (means of Foxp3high in lymphocytes: 150 µg/mL AcES 19.0% with p = 0.58; means of Foxp3high in 
CD4 + CD8+ T cells: 150 µg/mL AcES 44.5%, p = 0.08; Fig. 1B). In contrast, AcES at 15 µg/mL was associated with 
a slight decrease in Foxp3high cells in lymphocytes and CD4+ T cells (means of Foxp3high in lymphocytes: 15 µg/
mL AcES 12.4% with p = 0.04; means of Foxp3high in CD4+ T cells: 15 µg/mL AcES 12.0%, p = 0.04; Fig. 1A and B).
AcES and TcES elevate Helios expression in canine Foxp3high lymphocytes. Incubation of PBMCs 
in the presence of AcES as well as TcES at 150 µg/mL caused Foxp3high lymphocytes to significantly increase the 
expression of Helios (means: medium 23.6%, AcES 64.1% with p = 0.004, TcES 45.1% with p = 0.03; Fig. 1C). This 
effect was much lower for AcES at 15 µg/mL, while it was absent after treatment with TcES at 15 µg/mL (means: 
15 µg/mL AcES 32.5% with p = 0.13, 15 µg/mL TcES 22.6% with p = 0.71).
AcES and TcES decrease CD25++ Foxp3high lymphocytes. Analysing the co-expression of Foxp3 
and CD25 showed ES products to decrease CD25++ Foxp3high lymphocytes at 150 µg/mL (means: 150 µg/mL 
AcES 1.1% with p = 0.01, 150 µg/mL TcES 1.1% with p = 0.005, medium 8.7%; Fig. 1D). The decline in CD25++ 
Foxp3high lymphocytes was much lower at 15 µg/mL (means: 15 µg/mL AcES 6.8% with p = 0.32, 15 µg/mL TcES 
3.9% with p = 0.04). This effect was less distinct with loss of statistical significance when analysing the CD25+ 
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Figure 1. Tregs inducing assay. (A) Treatment of canine PBMCs with TcES at 150 µg/mL caused an increase in 
Foxp3+ and Foxp3high. Although single individuals show increased frequencies of Foxp3+ lymphocytes after 
treatment with AcES at 150 µg/mL (illustrated by the flow cytometric plots) this effect did not achieve statistical 
significance. In contrast, AcES at 15 µg/mL was associated with a slight decrease in Foxp3 expression in 
lymphocytes. (B) Three-colour flow cytometry revealed the TcES-associated increase in Foxp3high lymphocytes 
to be associated with CD4+, CD4+ CD8+ double-positive and CD4- CD8- double-negative subsets, while this 
effect was lower in CD8+ T cells. Compared to TcES, treatment with AcES at 150 µg/mL was associated with 
a much lower elevation in Foxp3high expression by lymphocytes and CD4+ CD8+ T cells. (C) Cultivating the 
cells in the presence of 150 µg/mL AcES or TcES induced marked increase in Helios expression by Foxp3high 
lymphocytes. (D) Treatment of canine PBMCs with ES products was associated with decreased frequencies 
of CD25+ and CD25++ cells within Foxp3high lymphocytes and this effect was most obvious at 150 µg/
mL. P-values were calculated according to paired t-test. Error bars represent standard error of mean (SEM). 
FSC = forward scatter, SSC = side scatter. Experiments were repeated six times at two different time points.
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subset in Foxp3high lymphocytes (means: 150 µg/mL AcES 7.7% with p = 0.17, 15 µg/mL AcES 21.5% with 
p = 0.87, 150 µg/mL TcES 5.7% with p = 0.07, 15 µg/mL TcES 12.0% with p = 0.053, medium 20.4%).
AcES and TcES induce IL-10 production by canine lymphocytes. For investigating whether ES 
antigens are capable of increasing IL-10 production, PBMCs were pulsed with AcES or TcES following stimu-
lation with lipopolysaccharide (LPS) or medium. Analysis of culture supernatants using a canine IL-10 sand-
wich enzyme-linked immunosorbent assay (ELISA) showed both AcES and TcES to be capable of increasing 
IL-10 secretion (Fig. 2A). For AcES this effect was higher at 15 µg/mL, while TcES-associated IL-10 secretion 
was stronger at 150 µg/mL and was only present when cells were co-stimulated with LPS (means of IL-10 in pg/
mL: 15 µg/mL AcES: 468.1, p = 0.031; 150 µg/mL AcES: 455.7, p = 0.063; 15 µg/mL AcES/LPS: 878.7, p = 0.033; 
150 µg/mL AcES/LPS: 512.7, p = 0.054; 15 µg/mL TcES: 47.5, p = 0.44; 150 µg/mL TcES: 133.6, p = 0.22; 15 µg/
mL TcES/LPS: 613.8, p = 0.088; 150 µg/mL TcES/LPS: 1184.6, p = 0.025; medium: 37.5; LPS: 271.0). To verify 
changes in IL-10 expression on the single cell level, intracellular cytokine staining was performed (Fig. 2B-D). 
This confirmed ES products to slightly increase IL-10 expression at 150 µg/mL and further showed that lym-
phocytes but not monocytes are responsible for this effect (means of IL-10+ in lymphocytes: medium: 13.1%; 
LPS: 12.3%; 150 µg/mL AcES: 22.6%, p = 0.04; 150 µg/mL AcES/LPS: 20.9%, p = 0.006; 150 µg/mL TcES: 22.1%, 
p = 0.02; 150 µg/mL TcES/LPS: 23.0%, p = 0.005; 15 µg/mL AcES: 12.4%; 15 µg/mL AcES/LPS: 12.9%; 15 µg/mL 
TcES: 14.9%; 15 µg/mL TcES/LPS: 12.1%).
ES-induced IL-10 expression is mainly related to CD8+ T cells. To further characterise the pheno-
type of IL-10+ lymphocytes, we used three-colour flow cytometry for IL-10, CD4 and CD8 (Fig. 3A). Gating 
on different T cell subsets revealed CD8+ T cells as being the main source of ES-induced IL-10 (means of 
IL-10+ in CD8+ T cells: medium: 13.9%; LPS: 16.1%; 150 µg/mL AcES: 26.6%, p = 0.02; 150 µg/mL AcES/LPS: 
25.2%, p = 0.02; 150 µg/mL TcES: 26.2%, p = 0.04; 150 µg/mL TcES/LPS: 27.0%, p = 0.04; 15 µg/mL AcES: 17.1%, 
p = 0.001; 15 µg/mL AcES/LPS: 13.3%; 15 µg/mL TcES: 15.1%; 15 µg/mL TcES/LPS: 16.6%).
In contrast, treatment with ES at 150 µg/mL caused a mild decrease in IL-10 within the CD4- CD8- 
double-negative subset and this effect was more obvious when cells were stimulated with LPS (medium: 19.8%; 
LPS: 19.1%; 150 µg/mL AcES: 14.6%, p = 0.3; 150 µg/mL AcES/LPS: 14.3%, p = 0.02; 150 µg/mL TcES: 12.8%, 
p = 0.06; 150 µg/mL TcES/LPS: 12.2%, p = 0.002; 15 µg/mL AcES: 18.5%; 15 µg/mL AcES/LPS: 20.4%; 15 µg/mL 
TcES: 19.9%; 15 µg/mL TcES/LPS: 19.3%).
Analysis of Foxp3 expression in IL-10+ lymphocytes showed varying amounts of IL-10+ Foxp3high cells rang-
ing from 0.2 up to 68.4% (mean: 19.1%; Fig. 3B). Although the data suggest ES products to slightly diminish the 
frequencies of IL-10+ Foxp3+ cells in the absence of LPS stimulation, this effect did to gain statistical signifi-
cance. For AcES at 150 µg/mL, however, this effect was more obvious in the presence of LPS (LPS: 15.6%; 150 µg/
mL AcES/LPS: 9.8%, p = 0.02).
Co-staining for IL-10 and IL-17 showed low frequencies of IL-10+ lymphocytes to express IL-17 (mean: 
18.7%; Fig. 3C) although co-expression was higher (up to 67.6%) in single individuals. Interestingly, ES antigens 
were capable of elevating IL-17 expression in LPS-stimulated IL-10+ lymphocytes which gained statistical sig-
nificance for TcES at 15 µg/mL (means of IL-17+ in LPS-stimulated IL-10+ lymphocytes: LPS: 12.6%; 150 µg/
mL AcES: 14.1%, p = 0.53; 15 µg/mL AcES: 17.3%, p = 0.09; 150 µg/mL TcES: 20.1%, p = 0.17; 15 µg/mL TcES: 
14.3%, p = 0.02). Although the data may further suggest a decrease in IL-17 expression by unstimulated IL-10+ 
lymphocytes this trend was not significant.
AcES and TcES inhibit polyclonal T cell proliferation. To evaluate whether ES antigens are capable 
of reducing polyclonal T cell proliferation, carboxyfluorescein succinimidyl ester (CFSE)-labelled PBMCs were 
stimulated with phytohaemagglutinin-L (PHA-L) for 4 days and proliferation of lymphocytes as well as CD4 
and CD8 subsets was then analysed using flow cytometry. This demonstrated pulsing with TcES at 150 µg/mL to 
significantly prevent mitogen-induced proliferation of lymphocytes (Fig. 4A) and this effect was present in both 
CD4+ (Fig. 4B) and CD8+ (Fig. 4C) cells (CFSE mean fluorescence intensity, MFI, of lymphocytes: 150 µg/mL 
TcES 2313.6 with p < 0.001, PHA-L control 404.4; CD4+ T cells: 150 µg/mL TcES 2104.4 with p < 0.001, PHA-L 
control 454.4; CD8+ T cells: 150 µg/mL TcES 2051 with p = 0.001, PHA-L control 533.6). AcES revealed a similar 
effect on the proliferation of lymphocytes and CD4+ T cells, while the anti-proliferative capability was lower 
with loss of statistical significance in CD8+ T cells (CFSE MFI for lymphocytes: 150 µg/mL AcES 1480.8 with 
p = 0.006; CD4+ T cells: 150 µg/mL AcES 1999.6 with p = 0.0002; CD8+ T cells: 150 µg/mL AcES 1173.8 with 
p = 0.5). To rule out unspecific effects of proteins, such as covering of mitogen receptors, being responsible for 
this observation, ES products were replaced by bovine serum albumin (BSA) at 15 and 150 µg/mL as a further 
control. However, in contrast to ES products, BSA did not reduce PHA-L-induced proliferation of lymphocytes, 
CD4+ or CD8+ T cells (CFSE MFI lymphocytes: 150 µg/mL BSA 601.8 with p = 0.99, 15 µg/mL BSA 489.8 with 
p = 0.99; CD4+ T cells: 150 µg/mL BSA 449.4 with p = 1.0, 15 µg/mL BSA 385.12 with p = 0.99; CD8+ T cells: 
150 µg/mL BSA 639.8 with p = 0.99, 15 µg/mL BSA 500.02 with p = 1.0).
AcES and TcES impair LPS-induced maturation of canine moDCs. To investigate the effect of ES 
antigens on the maturation of monocyte-derived DCs (moDCs), flow cytometry was used to analyse their expres-
sion of major histocompatibility complex class-II (MHC-II) and the co-stimulatory molecule CD80 after Toll-like 
receptor 4 (TLR4) stimulation. This demonstrated pulsing of moDCs with TcES before LPS stimulation to signif-
icantly reduce their MHC-II upregulation (MFI: TcES/LPS 1386.03 with p = 0.001, TcES 1169.23 with p = 0.0009, 
medium control 1182.43 with p = 0.005, LPS control 1603.85; Fig. 5A). Interestingly, excelling the effect of TcES, 
pulsing of moDCs with AcES resulted in MHC-II expression lower than that of the medium control and this effect 
was independent from the presence of LPS (MFI: AcES/LPS 759.68 with p = 0.03, AcES 816.08 with p = 0.04). 
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Figure 2. IL-10 expression. (A) ELISA revealed both AcES and TcES to be capable of increasing IL-10 secretion 
by canine PBMCs. For AcES this effect was more obvious at 15 µg/mL. In contrast, TcES-associated IL-10 
secretion was stronger at 150 µg/mL and was only detected when cells were co-stimulated with LPS. (B) For 
analysis of intracellular IL-10 staining, PBMCs were gated on lymphocytes and monocytes based on side (SSC) 
and forward scatter (FSC) morphology. This revealed (C) lymphocytes but not (D) monocytes to be responsible 
for ES-induced IL-10 expression and the effect was independent from stimulation with LPS. P-values were 
calculated according to Wilcoxon signed rank test (ELISA without LPS stimulation) or paired t-test (ELISA with 
LPS stimulation, intracellular cytokine staining). Error bars show standard error of mean (SEM). Experiments 
were repeated six times at two different time points.
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Figure 3. Characterisation of IL-10+ lymphocytes. (A) Three-colour flow cytometry showed CD8+ 
lymphocytes to be the main source of ES-induced IL-10 expression. In contrast, CD4- CD8- double-negative 
lymphocytes revealed lower IL-10 expression after ES treatment at 150 µg/mL. (B) ES antigens were associated 
with a mild decrease in Foxp3high cells within IL-10+ lymphocytes in the absence of LPS stimulation, although 
the finding failed to reach statistical significance. For AcES at 150 µg/mL, this effect was more obvious when 
cells were stimulated with LPS (C) Co-staining for IL-17 showed ES antigens to be capable of elevating IL-17 
expression in LPS-stimulated IL-10+ lymphocytes and this effect was significant for TcES at 15 µg/mL. 
Although the data may suggest a decrease in IL-17 expression by unstimulated IL-10+ lymphocytes this effect 
failed to reach statistical significance. P-values were calculated according to paired t-test. Error bars illustrate 
standard error of mean (SEM). FSC = forward scatter, SSC = side scatter. Experiments were repeated six times at 
two different time points.
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This was in contrast to pulsing with TcES without subsequent LPS stimulation which did not change the baseline 
MHC-II expression of moDCs (MFI: 1169.23 with p = 0.9).
Similar to MHC-II, LPS-induced upregulation of CD80 was prevented when moDCs were pulsed with ES 
preparations (MFI: AcES/LPS 133.68 with p = 0.031, AcES 110.5 with p = 0.031, TcES/LPS 118.84 with p = 0.031, 
TcES 111.68 with p = 0.031, LPS control 220.1, medium control 149.18 with p = 0.031). In addition, expression of 
CD80 by ES-pulsed moDCs was lower than for medium control and this effect achieved statistical significance for 
AcES without subsequent LPS stimulation (p = 0.031).
Figure 4. T cell proliferation assay. Cultivating CFSE-stained PBMCs in the presence of ES antigens revealed 
TcES to be capable of reducing PHA-induced lymphocyte proliferation (A) at 150 µg/mL and this was detectable 
in both CD4+ (B) and CD8+ (C) T cells. AcES showed similar effects in lymphocytes and CD4+ cells, while 
the anti-proliferative capability was lower with loss of statistical significance in CD8+ T cells. P-values were 
calculated according to one-way ANOVA followed by the Tukey’s honest significant difference post-hoc test. 
Error bars represent standard error of mean (SEM). FSC = forward scatter, SSC = side scatter. Experiments were 
repeated six times at two different time points.
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Discussion
Modulating and suppressing the immune system is an important skill of many parasites by which they are able 
to influence the host’s immune response26. However, little is known about the immunomodulatory pathways 
adopted by canine parasites during their co-evolution alongside the dog’s immune system. We recently demon-
strated that Foxp3+ lymphocytes are elevated in the intestinal mucosa of nematode-infected dogs in vivo and 
hypothesised a Treg-inducing potential for canine intestinal helminths in the natural host41. Therefore the present 
study aimed to investigate whether the zoonotic organisms A. caninum and T. canis mediate immunosuppression 
in dogs and whether this includes the induction of Tregs. Confirming our hypothesis, the results demonstrated 
CD4+ Foxp3high T cells to be elevated in PBMCs after cultivation in the presence of TcES. This finding is in 
accordance with observations in mice demonstrating Foxp3 to be increased on both the mRNA and protein levels 
in T. canis-infected animals and interestingly this effect was enhanced when mice obtained TcES prior to infec-
tion37. Additionally, a Treg-inducing ability is also known for several murine helminths including Brugia malayi42, 
H. polygyrus43 and Strongyloides ratti44. Tregs comprise a small Th subset with anti-inflammatory activity by 
which the immune system can maintain a homeostatic environment in the steady state and prevent exaggerated 
inflammation during immune responses on a cellular level45, 46. This is of particularly high importance in the 
context of the intestinal mucosa as induction and expansion of Tregs is essential for establishing oral tolerance46. 
Considering the immunoregulatory potential of intestinal parasites, several studies hypothesised their thera-
peutic potential for chronic inflammatory disorders such as inflammatory bowel disease, which is hallmarked 
by a breakdown of intestinal homeostasis associated with a decline in mucosal Tregs19, 20, 41. Interestingly, TcES 
also caused increased Foxp3 expression in CD4+ CD8+ double-positive T cells. In dogs, this subset represents a 
heterogeneous population of activated T cells in the peripheral blood that can develop from CD4+ and CD8+ T 
cells47. Our observation that these cells express Foxp3 is in accordance to a previous study on canine Tregs in the 
peripheral blood and popliteal lymph node48. Although canine CD4+ CD8+ T cells are suggested to exert a reg-
ulatory function49, the targets of this mechanism still remain unknown. Therefore, additional studies are needed 
to further investigate the role of canine CD4+ CD8+ double-positive T cells in helminth infection.
Treatment with ES extracts was not associated with elevation of the CD25++ compartment of Foxp3high lym-
phocytes which was in contrast to the effect of Concanavalin A (ConA). CD25 is classically linked to the pheno-
type of canine Tregs and the degree of CD25 expression in ConA-stimulated CD4+ T cells is correlated with Treg 
Figure 5. DC maturation assay. Pulsing of moDCs with ES products before LPS stimulation revealed both 
AcES and TcES to be capable of preventing the upregulation of MHC-II (A) and CD80 (B). For MHC-II, AcES 
was exceeding the effect of TcES by causing moDCs to downregulate MHC-II expression compared to medium 
control. Although ES preparations caused downregulation of CD80 compared to medium control this effect was 
statistically significant only for AcES without subsequent LPS stimulation. P-values were calculated according to 
paired t-test (for MHC-II) and Wilcoxon signed rank test (for CD80). Error bars show standard error of mean 
(SEM). Experiments were repeated six times at two different time points.
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function suggesting CD25++ Foxp3high T cells to be activated canine Tregs48. The results may therefore suggest 
ES products to induce canine Tregs in a less activated state. However, this finding may otherwise indicate that the 
phenotype of activated canine Tregs can differ depending on the stimulus (e.g., ConA versus parasitic antigen), 
which needs to be investigated in further studies.
Compared to TcES, treatment with AcES caused a lower increase in Foxp3high cells in canine lymphocytes 
and CD4+ CD8+ double-positive T cells. Although this effect did not achieve statistical significance, it is partly 
similar to data from humans as the levels of circulating Tregs are elevated in patients infected with N. americanus, 
a human hookworm closely related to A. caninum50. In addition, we found AcES and TcES to cause marked upreg-
ulation of Helios within Foxp3high lymphocytes. Helios is a member of the Ikaros transcription factor family that 
was initially thought to discriminate naturally occurring from peripherally induced Tregs51. Its expression has 
been also demonstrated in canine PBMCs and, based on the literature, the authors suggested that Helios might 
be a suitable marker for thymic-derived Tregs in dogs48. However, subsequent studies revised the hypothesis of 
Thornton et al.51 by showing that Helios expression can be induced in Foxp3+ T cells52 and by demonstrating 
Helios+ and Helios- cells within natural occurring Tregs53. Functionally, Helios has been linked to T cell activa-
tion and proliferation54, and its expression is necessary for a stable inhibitory Treg activity55. Although functional 
studies are needed to confirm the impact of Helios in dogs, its upregulation by canine Foxp3high lymphocytes after 
treatment with ES products suggests A. caninum and T. canis larvae to activate canine Tregs and to improve their 
regulatory activity.
The mechanism by which parasites can raise the Treg frequency may encompass direct and indirect effects. 
For instance, Treg induction may be facilitated by a parasite-related homeostatic environment, which includes 
the shift to a pro-regulatory cytokine milieu56. Moreover, parasites can support Treg generation by modulating 
DCs, for example by preventing their maturation, which may then guide naïve T cells to differentiate into a reg-
ulatory subset. This has been illustrated for H. polygyrus or Echinococcus granulosus in which treatment of DCs 
with respective ES antigens elevate their Treg-inducing capacities57, 58. The results presented here show both AcES 
and TcES to impair upregulation of MHC-II and CD80 after TLR4 stimulation, thus implicating A. caninum and 
T. canis to be capable of reducing DC maturation in dogs. However, further studies should verify whether DCs 
pulsed with AcES or TcES are indeed more competent in modulating canine Tregs. Interestingly, AcES seems 
to be more potent in reducing the MHC-II expression of moDCs than TcES. Despite the fact that this could 
implicate different modes of action by which AcES and TcES influence DCs, the effect may further be related to 
quantitative differences in the fractions of ES antigens responsible for this finding. In addition to the interaction 
with DCs, parasites can directly drive Treg differentiation by secreting homologues that mimic the function of 
host molecules. For instance, this has been demonstrated for ES products of H. polygyrus that induce expression 
of Foxp3 via a TGF-β-like signalling pathway16. The identification of Ac-daf-7 and Ac-dbl-1 in larval secretions 
of A. caninum, both of which are TGF-β-like ligands with homology to proteins of Caenorhabditis elegans, may 
implicate AcES to be capable of influencing T cells independent from DCs59, 60. Therefore, conditions required 
for Treg induction and/or modulation by AcES and TcES in dogs should be further addressed in future studies to 
better define whether this is dependent on or independent of the presence of DCs.
Confirming the immunoregulatory potential of AcES and TcES in the definitive host on the cytokine level, 
we show ES antigens to enhance IL-10 secretion of canine lymphocytes. This is in accordance with previous 
studies on the cytokine pattern induced by larval secretions of A. caninum and T. canis in humans and/or mice 
showing them to be dominated by anti-inflammatory molecules including IL-1017, 35, 36. Similarly, PBMCs of 
dogs infected with T. canis during pregnancy are reported to show higher secretion of IL-1039. IL-10 is one of the 
most important anti-inflammatory cytokines as reviewed by Sabat et al.61 and its ablation induces severe failure 
in immune homeostasis causing inflammatory disorders such as colitis62. In the context of helminth infection, 
parasite-induced IL-10 secretion may enhance the homeostatic capacity of the host including elevated generation 
of Tregs63. In addition, IL-10 may also interfere with the maturation of antigen-presenting cells by preventing the 
transport of peptide-laden MHC-II molecules to the cell surface64. This could represent a possible mechanism by 
which AcES and TcES stop MHC-II upregulation by LPS-stimulated canine moDCs.
Three-colour flow cytometry revealed CD8+ T cells to be mainly responsible for ES-induced IL-10 expres-
sion. Although their marked increase in IL-10 suggests a regulatory function, it remains speculative whether 
they represent CD8+ Tregs. Being present in much lower frequencies than their CD4+ counterpart, CD8+ 
Foxp3+ Tregs have been described in humans, mice and dogs48, 65. In the context of helminth infection, Cuéllar 
et al. showed murine splenic CD8+ cells, which are further characterised by the expression of Foxp3, CD25 and 
remarkable amounts of IL-10, to be responsible for suppressive effects of the recombinant metalloproteinase 
Ac-TMP-2 derived from adult A. caninum15. This implicates an important role of IL-10 in murine splenic CD8+ 
Tregs, which has been substantiated by others who found IL-10 to be required for the suppressive capacity of 
this cell population66. Interestingly, in murine H. polygyrus infection, CD8+ Tregs isolated from the intestinal 
lamina propria were capable of suppressing splenocyte proliferation in a contact-dependent manner unrelated to 
the presence of IL-1067. The results of the present study suggest that IL-10+ CD8+ T cells play a significant role 
in helminth-induced immune regulation by T. canis and A. caninum in dogs. Therefore, future studies should 
continue in characterising their phenotype and regulatory capacity, and thereby elucidating the role of CD8+ T 
cells in canine helminth infection.
Interestingly, ES treatment prior to LPS stimulation caused mildly increased IL-17 expression in IL-10+ 
lymphocytes. However, it remains unclear whether these IL-10+ IL-17+ double-positive cells represent 
IL-10-producing Th17 cells or if this finding just reflects IL-17 expression by other lymphocytes. Considering the 
upregulation of IL-17 in circulating Tregs of N. americanus-infected human patients50 and in the peripheral blood 
of T. canis-infected mice38, subsequent studies might perform co-localisation of IL-10, IL-17 and other Th-specific 
molecules to further elucidate the phenotype of canine ES-induced IL-10+ IL-17+ cells.
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Besides the analysis of antigen-specific effects, proliferation assays have been used to investigate whether para-
sites are capable of reducing polyclonal T cell activation. While this can be indirectly achieved by parasite-induced 
Tregs15, 16, several studies provide evidence of worm-related factors by which they can directly interfere with 
lymphocyte proliferation in response to mitogens as demonstrated for Ascaris lumbricoides, H. polygyrus, N. 
americanus and Trichuris trichiura50, 68, 69. Similar effects have also been reported for A. caninum when adult 
worm extracts or living infective larvae were added to human mitogen-stimulated PBMCs17. Interestingly, the 
anti-proliferative effect was elevated in those patients infected with N. americanus17. In the present study, we 
demonstrate that larval secretions of A. caninum and T. canis inhibit the proliferation of canine PHA-stimulated 
T cells. With respect to the mechanism responsible for this effect, the anti-proliferative potential of adult worm 
secretions of N. americanus on human PBMCs is directly dependent on the presence of CD4+ CD25+ Foxp3+ 
Tregs50. Moreover, this effect may be further attributed to CD8+ Tregs as they are shown to outrun the suppres-
sive capacity of CD4+ Tregs on lymphocyte proliferation15, 67. To better define the circumstances essential for 
the inhibition of polyclonal immune cell activation during canine helminth infection, additional studies should 
investigate the contribution of soluble and cellular factors.
In summary, we demonstrated several effects by which A. caninum and T. canis can interfere with the canine 
immune system. These include the induction and/or modulation of Foxp3high T cells, an increase in CD8+ 
IL-10+ T cells, inhibition of polyclonal T cell proliferation and the prevention of DC maturation. These effects 
are mediated by secretions of infective larvae, suggesting that the anti-inflammatory capacities already evolve 
early in the parasitic life-cycles, i.e. in the pre-adult stages. Remarkably, the present study further shows many 
of the immunomodulatory effects to be mediated by both nematodes. Considering the differences between 
A. caninum and T. canis, which are not only obvious on a phylogenetic level but also illustrated by sodium dodecyl 
sulphate polyacrylamide gel electrophoresis (SDS-PAGE) of ES antigens or proteomic studies29, 31, this may raise 
the question whether the findings presented here are related to common molecules shared by both organisms or 
attributed to distinct mechanisms that differ between both species. Therefore, future studies may focus on distinct 
ES fractions or single molecules to further increase the understanding of parasite-related immune regulation.
Material and Methods
Ethics statement. All animal experiments were performed in accordance to the German Animal 
Welfare Act as well as national and international guidelines for animal welfare. The animal experiments were 
approved by the Institutional Animal Care and Use Committee (IACUC) of the Lower Saxony State Veterinary 
Office for Consumer Protection and Food Safety (Niedersächsisches Landesamt für Verbraucherschutz und 
Lebensmittelsicherheit, Oldenburg, Germany; registration numbers: 33.19-42502-05-01A038, 33.19-42502-05-
15A587, 33.19-42502-05-16A024).
Animals. For generating nematode larvae, dogs were experimentally infected with T. canis or A. caninum, 
respectively, at the Institute for Parasitology (University of Veterinary Medicine Hannover). For isolating PBMCs, 
peripheral blood was obtained from dogs of various breeds, which were presented to the Unit of Reproductive 
Medicine (University of Veterinary Medicine Hannover) due to reasons unrelated to the present study and sam-
ples were only collected after the owner’s agreement. In addition, peripheral blood was also obtained from Beagle 
dogs permanently housed in the Unit of Reproductive Medicine for reasons unrelated to the present study. All 
dogs were free from apparent disorders according to the clinical examination. Owners’ dogs were routinely 
treated with anthelminthic drugs before blood sample collection. In the case of Beagles, absence of intestinal 
parasites was checked by parasitological examination of faecal samples.
Preparation of parasitic antigens. To obtain T. canis and A. caninum L3 for ES culture, eggs were 
obtained from faecal samples of experimentally infected dogs, these then being processed via the routine 
sedimentation-flotation technique. T. canis eggs were washed and embryonated in tap water at 25 °C for about 
4 weeks. Larval hatching was carried out in vitro as described elsewhere70. For A. caninum, obtained eggs were 
incubated in a coproculture for about one week until development of L3. Larvae were exsheathed by incubation 
with sodium hypochlorite for 15 min at 37 °C.
A. caninum and T. canis L3 were washed approximately 10 times in sterile phosphate-buffered saline (PBS, pH 
7.4) containing antibiotics (100 U/mL penicillin, 100 µg/mL streptomycin) followed by cultivation under standard 
conditions in RPMI-1640 supplemented with 1% glucose and antibiotics as follows: 100 U/mL penicillin, 100 µg/
mL streptomycin, 50 µg/mL gentamycin, 0.5 µg/mL amphotericin B. Parasites were cultured for up to 5 weeks 
and culture dishes were monitored daily for larval viability (at least 80% viable larvae to obtain ES products) and 
absence of bacterial contamination. Tissue culture supernatants were collected weekly and concentrated using a 
centrifugal filtration unit with a 3 kDa cut-off (Vivaspin® Centrifugal Concentrators, Sartorius AG, Göttingen, 
Germany) according to the manufacturer’s recommendations. Extracts were then filtered through a low-binding 
disposable 0.22 µm filter and stored at -80 °C for up to 6 months until use. Protein concentrations of ES extracts 
were estimated by measuring the absorbance at 280 nm with a NanoDrop ND-1000 Spectrophotometer and 
results were calculated using logistic regression analysis based on a bovine gamma globulin standard curve (see 
Supplementary Method S1). SDS-PAGE showed no major differences between batches of ES extracts. ES prepa-
rations were further found to have a mean endotoxin content of 0.52 EU/mL as determined by using the Pierce™ 
LAL Chromogenic Endotoxin Quantitation Kit (Thermo Fischer Scientific, Waltham, Massachusetts, USA).
PBMC isolation. For PBMC isolation, 20 mL of heparinised canine peripheral blood were diluted 1:2 in 
PBS followed by density gradient centrifugation (Histopaque®-1077, Sigma Aldrich, Taufkirchen, Germany) at 
700 × g for 30 min. Mononuclear cells were collected and washed 3 times in PBS containing 0.02% 1 M ethylen-
ediaminetetraacetic acid (EDTA). Isotone erythrolysis was applied to eliminate contaminating erythrocytes if 
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appropriate. Cells were then resuspended in RPMI-1640 supplemented with 10% inactivated foetal calf serum 
(FCS) and antibiotics (100 U/mL penicillin, 100 µg/mL streptomycin).
Cell culture. To analyse whether ES antigens are able to induce Tregs, PBMCs were cultured in 96 well 
microplates at 0.5 × 106 cells/well and stimulated with ES antigens at 15 and 150 µg/mL, respectively, or medium 
under standard culture conditions. ConA, which is known to induce canine Tregs in vitro48, was further used at 
5 µg/mL as control. After 72 hours, cells were harvested and analysed by flow cytometry regarding their expres-
sion of Foxp3, CD4 and CD8, Foxp3 and Helios, as well as Foxp3 and CD25.
For investigating the potential of larval ES antigens to induce IL-10 production, PBMCs were cultured in 96 
well microplates at 0.5 × 106 cells/well and pulsed with ES products at 15 and 150 µg/mL, respectively, following 
stimulation with LPS at 1 µg/mL (LPS-B5 Ultrapure, InvivoGen, Toulouse, France) or medium after 3 hours. 
ConA, LPS and medium were used as controls. After 24 hours, culture supernatants were collected and stored at 
-80 °C until further use.
To investigate IL-10-expressing cells on the single cell level, intracellular cytokine staining was used. For this 
purpose, PBMCs cultured in 96 well microplates at 0.5 × 106 cells/well were pulsed with AcES or TcES at 15 and 
150 µg/mL, respectively. After 3 hours, cells were supplemented with 1 µg/mL LPS or medium and cultured for 
a further 18 hours. Brefeldin A was added during the final 12 hours at 5 µg/mL. Finally, PBMCs were stained for 
IL-10, CD4 and CD8, IL-10 and Foxp3, as well as IL-10 and IL-17, respectively.
To further analyse the potential of ES products to suppress mitogen-induced lymphocyte proliferation, 
PBMCs labelled with CFSE were pulsed with AcES or TcES at 15 and 150 µg/mL, respectively, for 3 hours follow-
ing stimulation with PHA-L at 2.5 µg/mL in 96 well microplates at 0.5 × 106 cells/well. BSA at 15 and 150 µg/mL, 
respectively, was used as additional controls. After 4 days, cells were stained for CD4 and CD8 and analysed by 
flow cytometry.
MoDC maturation. To evaluate whether ES antigens are capable of modulating TLR4-mediated mat-
uration of antigen presenting cells, moDCs were generated as previously described with few modifications71. 
Briefly, PBMCs were cultured at 2 × 106 cells/mL in medium under standard culture conditions. After 24 hours, 
non-adherent cells were removed and adherent monocytes were cultured in the presence of 20 ng/mL canine 
recombinant IL-4 and 10 ng/mL canine recombinant GM-CSF for an additional 6 days. During this period, 
fully supplemented medium was changed after 3 days. Subsequently, moDCs were harvested by collecting 
non-adherent cells and pulsed with 150 µg/mL AcES or TcES for 24 hours in 96 well microplates (at least 20,000 
cells/well). MoDCs were then stimulated with LPS at 1 µg/mL or medium for a further 24 hours. LPS was used as 
control. MoDCs were subsequently analysed regarding the expression of MHC-II and CD80 by flow cytometry.
Flow cytometry. The following antibodies were used for surface staining: Rat anti-canine CD4 (clone 
YKIX302.9, Bio-Rad AbD Serotec, Puchheim, Germany) labelled with Lightning-Link® Rapid Atto633 (Innova 
Biosciences, Babraham, UK), rat anti- canine CD4:FITC (clone YKIX302.9, eBiosciences, Frankfurt am Main, 
Germany), rat anti-canine CD8:RPE and CD8:AF647 (clone YCATE55.9, Bio-Rad AbD Serotec), mouse 
anti-canine CD11c (clone CA11.6A1, obtained from Peter F. Moore, UC Davis, CA, US), mouse anti-canine 
CD25:PE (clone P4A10, eBiosciences), rat anti-canine MHC-II:FITC (clone YKIX334.2, Bio-Rad AbD Serotec) 
and hamster anti-mouse CD80:AF647 (clone 16-10A1, BioLegend, London, UK).
Antibodies for detecting intracellular antigens included polyclonal goat anti-canine IL-10 (AF735, R&D 
Systems, Wiesbaden, Germany) labelled with Lightning-Link® Rapid R-PE (Innova Biosciences), polyclonal 
goat anti-human IL-17 (AF-317-NA, R&D Systems), which has been recently shown to cross-react with canine 
IL-1772, labelled with Lightning-Link® Rapid FITC (Innova Biosciences), rat anti-mouse/rat Foxp3:eFluor660 
(clone FJK-16s, eBiosciences) and hamster anti-mouse/human Helios:AF488 (clone 22F6, BioLegend).
For cell surface staining, cells were washed twice in PBS containing 1% BSA and 0.01% sodium azide 
(PBS-BSA) followed by incubation with primary antibodies on ice for 45 min. For staining of moDCs, PBS sup-
plemented with 3% FCS, 1 mM EDTA and 0.01% sodium azide was used instead of PBS-BSA and Fc receptors 
were blocked by pre-incubation in 10% heat-inactivated dog serum for 15 min before adding primary antibod-
ies. For staining canine CD11c, after washing steps, R-PE-labelled F(ab’)2-fragments of goat anti-mouse IgG 
(Dianova, Hamburg, Germany) were applied for 30 min on ice. Cells were then washed twice in PBS-BSA and 
either resuspended in BD FACSFlow™ Sheath Fluid (Becton Dickinson, Heidelberg, Germany) or further used 
for intracellular staining procedures.
For detecting intracellular antigens, cells were fixed and permeabilised using the Foxp3 / Transcription Factor 
Staining Buffer Set (eBiosciences) according to the manufacturer’s instructions. Cells were pre-treated with 
heat-inactivated mouse, rat and dog serum (each 15%) to block Fc receptors followed by incubation with anti-
bodies for 45 min at ambient temperature. Cells were then washed and resuspended in FACSFlow™ Sheath Fluid.
Samples were analysed with a FACSCaliburTM flow cytometer (Becton Dickinson) within 2 hours by collect-
ing at least 60,000 events if available. Isotype-matched control antibodies were used as negative controls in equal 
concentrations. Data were analysed with FCS Express (De Novo Software) and FlowJo (Tree Star). Foxp3-stained 
lymphocytes were differentiated into a Foxp3+ and Foxp3high population according to isotype controls (0.5% and 
0.1%, respectively). CD25+ and CD25++ gates were set based on the 5.0% and 2.0% region of medium control 
lymphocyte cultures, respectively, which is in accordance to a previous investigation of canine Tregs48. IL-10+ 
lymphocytes were defined based on isotype controls (0.5% gate). For CD4, CD8 and IL-17 staining, positive cells 
were identified based on morphology as they were obviously detectable in flow cytometry plots.
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IL-10 ELISA. The amount of IL-10 in culture supernatants of stimulated PBMCs was determined using sand-
wich ELISA (Canine IL-10 Quantikine® ELISA kit, R&D Systems) according to the manufacturer’s instructions. 
Absorbance was measured at 450 nm and IL-10 concentrations were calculated using the 4-parameter logistic 
nonlinear regression model.
Statistical analysis. Statistical analyses were performed using R version 3.3.0 (https://www.R-project.org/). 
Initially, data were checked for normal distribution by means of the Shapiro-Wilk test. Accordingly, the two-tailed 
Wilcoxon signed-rank test was used to evaluate differences in the amounts of IL-10 in supernatants of PBMC 
cultures without LPS stimulation (n = 6 dogs) and in expression of CD80 by moDCs (n = 6 dogs). The two-tailed 
paired t-test was performed to calculated differences in the percentage of Foxp3+/++ cells in the Treg stimula-
tion assay (n = 6 dogs), to analyse differences in intracellular IL-10 expression (n = 6 dogs), to check for changes 
in IL-10 in supernatants of LPS-stimulated PBMCs (n = 4 dogs) and to evaluate differences in the expression of 
MHC-II (n = 6 dogs). One-way ANOVA followed by the Tukey’s honest significant difference post-hoc test was 
applied to evaluate differences in CFSE MFI for the proliferation assay (n = 5 dogs). P-values ≤ 0.05 were consid-
ered as statistically significant.
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